- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06168149
The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
Preterm Eylem Olgularında; Fetal Akciğer Elastografi Değerlerinin Respiratuvar Distres Gelişimi Ile İlişkisi
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The evaluate the potential of fetal lung elastography as a non-invasive method to predict and treatment respiratory complications in preterm neonates. FAE is an imaging method that measures the elasticity properties of fetal lung tissue using ultrasound technology. This method can be helpful in providing information about the development and respiratory function of the fetal lungs.
The advantages of FAE are:
It is a non-invasive method: FAE is performed using ultrasound technology and has no known maternal or fetal harm. It stands as a potentially safe method compared to current invasive tests.
It is cost-effective and easy to perform: FAE is a procedure performed using existing ultrasound equipment at no separate cost. Therefore, it can be easily implemented and repeated in clinical settings.
Fast results: FAE provides fast results by acquiring images in real time. This indicates that FAE can be a valuable diagnostic tool in emergency situations or when rapid decision-making is required.
A potential predictive tool: The results of this study may indicate that FAE values are a potential tool for predicting the risk of developing RDS. This could be an important step to develop early diagnosis and treatment strategies to improve the respiratory health of preterm newborns.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Yenimahalle
-
Ankara, Yenimahalle, Turkey (Türkiye), 06000
- Etlik City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-45 years old
- Single pregnant women who were followed up with a diagnosis of preterm labor between 24-33 weeks and who volunteered and consented to the study
- Measured at least 24 hours after antenatal corticosteroid and delivered within a maximum of 72 hours after measurement
Exclusion Criteria:
- Multiple pregnancies
- Amniotic fluid pathologies
- Fetal lung and liver diseases
- Fetal genetic and structural anomalies
- Signs and diagnoses of systemic maternal diseases
- Advanced maternal obesity preventing measurement
- Patients hospitalized with a diagnosis of preterm labor and discharged before delivery
- Presence of comorbid diseases of pregnancy (GDM, hypertensive diseases of pregnancy, PPROM, chorioamnionitis etc.)
- Pregnant women over 45 years of age, systemic conditions (history of chronic, mental, physical illness, severe renal, hepatic, gastrointestinal acute/chronic inflammatory disease, hyperthyroidism, hypothyroidism, hypertension, type 1/2 DM, history of malignancy, smoking, alcohol use)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Neonates with respiratory distress syndrome
A total of 80 patients with no systemic maternal disease findings and diagnoses, without chronic drug use, who were measured at least 24 hours after antenatal corticosteroids were administered during pregnancy, and whose delivery occurred within a maximum of 72 hours, will be included in our study as two case groups with and without RDS diagnosis in neonatal follow-up.
|
Elastography measurements are planned to be performed as in the studies "Feasibility of two-dimensional ultrasound shear wave elastography of human fetal lungs and liver: A pilot study" and "Feasibility of 2-D ultrasound shear wave elastography of fetal lungs in case of threatened preterm labour: a study protocol" in the literature examples section of the file.
|
|
Neonates who do not develop respiratory distress syndrome
A total of 80 patients with no systemic maternal disease findings and diagnoses, without chronic drug use, who were measured at least 24 hours after antenatal corticosteroids were administered during pregnancy, and whose delivery occurred within a maximum of 72 hours, will be included in our study as two case groups with and without RDS diagnosis in neonatal follow-up.
|
Elastography measurements are planned to be performed as in the studies "Feasibility of two-dimensional ultrasound shear wave elastography of human fetal lungs and liver: A pilot study" and "Feasibility of 2-D ultrasound shear wave elastography of fetal lungs in case of threatened preterm labour: a study protocol" in the literature examples section of the file.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fetal Lung Elastography Measurement
Time Frame: Prenatal (24-34 gestational weeks, before 72 hours to delivery)
|
Measurement of prenatal ultrasonographic shear wave elastographic values(kPa) of the fetus in cases of preterm labor
|
Prenatal (24-34 gestational weeks, before 72 hours to delivery)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahmet Kurt, 1, Ankara Etlik City Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AEŞH-EK1-2023-516
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome
-
PT. Prodia Stem Cell IndonesiaRumah Sakit Pusat Angkatan Darat Gatot SoebrotoRecruitingAcute Respiratory Distress SyndromeIndonesia
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruiting
-
Changchun Tuohua Pharmaceutical Co., Ltd.RecruitingAcute Respiratory Distress SyndromeChina
-
Southeast University, ChinaRecruitingAcute Respiratory Distress SyndromeChina
-
Southeast University, ChinaRecruitingAcute Respiratory Distress SyndromeChina
-
Ramos Mejía HospitalUniversidad de la RepublicaNot yet recruitingRespiratory Distress Syndrome (RDS)
-
Fayoum UniversityNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Ain Shams UniversityRecruitingAcute Respiratory Distress Syndrome (ARDS)Egypt
-
The Fourth Affiliated Hospital of Zhejiang University...Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
Clinical Trials on fetal lung elastography measurement
-
Centre Hospitalier Universitaire de BesanconCompletedPregnant WomanFrance
-
Centre Hospitalier Universitaire de BesanconCompletedPregnancy Complications | Obstetric Labor, PrematureFrance
-
Azienda Ospedaliero-Universitaria di ParmaCompletedChronic Obstructive Pulmonary Disease | Smoker LungItaly
-
Ain Shams Maternity HospitalCompletedMedical; Abortion, FetusEgypt
-
Ankara Etlik City HospitalNot yet recruitingChemotherapy-induced Peripheral Neuropathy | Tibial NeuropathyTurkey
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Inonu UniversityCompletedPrenatal Attachment, Maternal Expectations, Paternal InvolvementTurkey
-
University of TorontoThe Physicians' Services Incorporated Foundation; Stichting Oranjekliniek,...Completed
-
Université de SherbrookeCancer Research SocietyRecruiting
-
University of LiverpoolLiverpool Women's NHS Foundation TrustCompletedPreterm BirthUnited Kingdom